Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(e) On August 5, 2009, the Compensation Committee (the "Committee") of the Board
of Directors of Delphi Financial Group, Inc. (the "Company") granted
performance-contingent incentive options to purchase 200,000 shares of the
Company's Class A Common Stock (the "Stock") to each of Thomas W. Burghart,
Senior Vice President and Treasurer of the Company and of the Company's
subsidiary, Reliance Standard Life Insurance Company ("RSL"), Lawrence E.
Daurelle, President and Chief Executive Officer of RSL, and the other five
members of executive management of RSL, pursuant to the Company's 2003 Employee
Long-Term Incentive and Share Award Plan, as amended. Such options have a
ten-year term and an exercise price equal to $24.91 per share.
Pursuant to each of the related award agreements, 100,000 of such options will
vest if the aggregate consolidated Adjusted Pre-Tax Operating Income of Reliance
Standard Life Insurance Company of Texas, RSL's intermediate parent company, as
defined and computed under such option agreements ("APTOI"), for the four-year
performance period consisting of fiscal years 2009 through 2012 (the "Initial
Period") is at least $782.8 million. Otherwise, a reduced number of such options
will vest to the extent that the aggregate APTOI for such period exceeds
$738.3 million, determined by interpolating between zero and 100,000 according
to where the APTOI amount falls in the range between $738.3 million and
$782.8 million.
In addition, if the APTOI for the six-year performance period consisting of
fiscal years 2009 through 2014 is at least $1.351 billion, 200,000 of such
options, less the number of such options having vested for the Initial Period
(the "First Period Options"), will vest. Otherwise, a reduced number of such
options will vest to the extent that the aggregate APTOI for such period exceeds
$1.286 billion, determined by interpolating between zero and 200,000 according
to where the APTOI amount falls in the range between $1.286 billion and
$1.351 billion and subtracting the number of the First Period Options.
The general form of the award agreement relating to these options is attached to
this Form 8-K as Exhibit 10.1 and is incorporated herein by reference.